Interest Section Forum: 3526 IRSOC: Make Sublingual Immunotherapy One of Your Tools in Your Practice

AMA PRA Category 1 Credits^TM: 1.25
CE: 1.50

Upon completion of this session, participants should be able to:

• Comment on which patients would make good and which would make bad candidates for SLIT.
• Discuss safety issues concerning SLIT with grass pollen extracts, especially focused on practical similarities and differences in Europe and U.S.
• Give an overview of innovative formula of house dust mite SLIT, as are the tablets and use of adjuvants and argue how molecular diagnosis might have implications for immunotherapy.

Credit must be claimed by May 31, 2016. Any credit request on or after June 1, 2016 will be subject to an administrative fee.